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Abstract
Background: Urinary tract infections (UTI) are more frequent in type-2 diabetes mellitus patients than in subjects with
normal glucose metabolism. The mechanisms underlying this higher prevalence of UTI are unknown. However, cytokine
levels are altered in diabetic patients and may thus contribute to the development of UTI. Increased levels of free fatty acids
(FFA), as observed in obese patients, can induce IL-6 production in various cell types. Therefore we studied the effects of
the free fatty acid palmitate and bacterial lipopolysaccharide (LPS) on interleukin-6 (IL-6) and monocyte chemotactic
protein-1 (MCP-1) expression and secretion in cultured human bladder smooth muscle cells (hBSMC).
Methodology/Principal Findings: Biopsies were taken from patients undergoing cystectomy due to bladder cancer.
Palmitate or LPS stimulated hBSMC were analysed for the production and secretion of the IL-6, gp80, gp80soluble, gp130,
MCP-1, pSTAT3, SOCS3, NF-kB and SHP2 by quantitative PCR, ELISA, Western blotting, and confocal immunofluorescence. In
signal transduction inhibition experiments we evaluated the involvement of NF-kB and MEK1 in IL-6 and MCP-1 regulation.
Palmitate upregulates IL-6 mRNA expression and secretion via NF-kB dependent pathways in a concentration- and time-
dependent manner. MCP-1 was moderately upregulated by palmitate but was strongly upregulated by LPS involving NF-kB
and MEK1 dependent pathways. Soluble IL-6 receptor (gp80soluble) was downregulated by palmitate and LPS, while
membrane-bound gp80 was moderately upregulated. LPS increased SOCS3 and SHP2, whereas palmitate only induced
SOCS3. Secondary finding: most of the IL-6 is secreted.
Conclusions/Significance: Bacterial infection (LPS) or metabolic alterations (palmitate) have distinct effects on IL-6
expression in hBSMC, (i) short term LPS induced autocrine JAK/STAT signaling and (ii) long-term endocrine regulation of IL-6
by palmitate. Induction of IL-6 in human bladder smooth muscle cells by fatty acids may represent a pathogenetic factor
underlying the higher frequency and persistence of urinary tract infections in patients with metabolic diseases.
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Introduction
Urinary tract infections (UTI) are more frequent in patients with
diabetes mellitus than in subjects with normal glucose metabolism
and take a more severe course [1,2]. Women with diabetes require
longer and more aggressive antimicrobial treatment for UTI, and
have more recurrences of their UTI than non-diabetic women. The
hospitalization due to complications of the UTI occurs significantly
more often in women with diabetes [3]. Urine cytokine levels and an
increased adherence of the microorganisms to the uroepithelial cells
seem to be the main predictors of increased prevalence of both
asymptomatic and symptomatic bacteriuria in diabetic patients [4].
Whereas someauthors suggest glucosuria as diabetes-specific variable
potentially associated with symptomatic infection [5], no association
between bacteriuria and indicators of glycemic control, such as the
blood glucose level and the glycosylated hemoglobin value, have been
found by others [6]. In addition to chronic hyperglycemia, altered
fatty acid metabolism belongs to the metabolic alterations associated
with type-2 diabetes [7]. However,it is not known whether alterations
in circulating free fatty acids (FFA) may contribute to the increased
UTI frequency in patients with diabetes.
Bacterial UTI lead to upregulation of cytokines and growth
factors and recruitment of inflammatory cells by LPS [8,9]. IL-6
was shown to be the single most prominent cytokine detected in
the urine patients with UTI [10]. Low-grade chronic inflammation
is reflected by a 2–3-fold increase in the systemic levels of certain
PLoS ONE | www.plosone.org 1 May 2010 | Volume 5 | Issue 5 | e10882cytokines [11] as well as C-reactive protein (CRP), and an
association has been confirmed between low-grade systemic
inflammation and type-2 diabetes [12].
There is growing evidence that increased levels of FFA can induce
IL-6 production in various cell types,and might thereforebe involved
in the pathophysiology of UTI [13–15]. Elevated FFAs in obese
patients may provide a mechanistic link between increased fat mass
and the development of insulin resistance, glucose intolerance, and
beta-cell dysfunction that promote the onset of diabetes [7,16].
Palmitate induced accumulation of IL-6 is regulated dependently of
c-Jun N-terminal kinase in 3T3-L1 adipocytes [17], but is regulated
via NF-kB in myotubes [13], pointing to the existence of potential
tissue/cell specific regulatory mechanisms in inflammation. In
addition, palmitate could regulate monocyte chemotactic protein-1
(MCP-1) expression in adipose tissue [18], human vascular umbilical
vein cells (HUVEC) and rat vascular smooth muscle cells [19].
Figure1.PalmitateeffectsonIL-6andMCP-1mRNAandproteinlevels.Time- and concentration-dependentregulation of IL-6 andMCP-1 protein
(A, C) and mRNA (B, D). IL-6 protein content (A) was measured in cytosol (white bars, ng/mg) and supernatant (black bars, ng/ml), while MCP-1 protein was
measured exclusively in supernatant (C, ng/ml). All bars indicatedifferencetomedium control. For eachmeasurement a medium treated control was used.
Data are shown as mean and SEM. Significant differences are indicated by lines. mRNA (B, D) was normalized to natural logarithm LN.
doi:10.1371/journal.pone.0010882.g001
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PLoS ONE | www.plosone.org 2 May 2010 | Volume 5 | Issue 5 | e10882The aim of the present study was to investigate IL-6 and MCP-1
regulation in hBSMC by acute bacterial infection (LPS stimula-
tion) and metabolic alterations (palmitate) as potential risk factor
for chronic bladder inflammation.
Results
Treatment of hBSMC with FFA palmitate (up to 48 hrs)
resulted in significantly increased IL-6 protein concentrations in
the supernatant, but not in the cytosol (Fig. 1A) A similar pattern
was observed for palmitate stimulated IL-6 mRNA expression
(Fig. 1B). Increased IL-6 secretion into the medium was dependent
on palmitate concentration and time.
In contrast, stimulation with LPS led to IL-6 protein upregulation
in the supernatant while levels decreased with time in the cytosol
(Fig. 2A). There was no concentration- dependent regulation of IL-6
mRNA (Fig. 2B). In addition total IL-6 expression was only about
25% of IL-6 protein produced upon palmitate stimulation (Fig. 2A).
While MCP-1 showed similar regulation of the mRNA (Fig. 1D),
this concentration- and time-dependent upregulation was not
Figure 2. LPS effects on IL-6 and MCP-1 mRNA and protein levels. Time- and concentration- dependent regulation of IL-6 and MCP-1 protein
(A, C) and mRNA (B, D). IL-6 protein content (A) was measured in cytosol (white bars, ng/mg) and supernatant (black bars, ng/ml), while MCP-1 protein
was measured exclusively in supernatant (C, ng/ml). All bars indicate difference to medium control. For each measurement a medium treated control
was used. Data are shown as mean and SEM. Significant differences are indicated by lines. Post-hoc Bonferroni test was used after ANOVA.
Significance level was p,0.05. mRNA (B, D) was normalized to natural logarithm LN.
doi:10.1371/journal.pone.0010882.g002
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constant over 48 hrs and was highest at low palmitate concentra-
tion (Fig. 1C). Upon LPS stimulation the MCP-1 protein in the
supernatant and in the cytosol decreased time- and concentration-
dependent (Fig. 2C). MCP-1 mRNA showed a comparable
downregulation with time but only moderate decrease with
increasing concentrations of LPS (Fig. 2D).
We found a transient upregulation of the mRNA of IL-6
receptor protein gp80 and its soluble form gp80 soluble (Fig. 3A).
After 16 hrs of incubation the gp80 mRNA was still high while the
mRNA of gp80soluble was significantly downregulated. This
opposite regulatory effect on mRNA levels was most prominent
with low palmitate concentration (0.125 mM) but was still present
at higher concentrations (Fig. 3A). Gp80 protein was significantly
downregulated as early as after 8 hrs incubation lasting up to
24 hrs. However, after 48 hrs incubation with 0.25 mM palmitate
the effect was reversed. This high level expression of gp80 was
concentration-independent (Fig. 3B).
The effects of LPS stimulation on gp80 and gp80soluble mRNA
are comparable to palmitate induced regulation (Fig. 4A,
C), except for a significant initial upregulation of gp80 and
gp80 soluble after 8 hrs. After 48 hrs there was an opposite
regulation of cytosolic gp80 protein, which was increased by
palmitate (0.25 mM) but decreased by LPS (1 mg/ml). Prominent
downregulation of pSTAT3 protein was evident in LPS
stimulated cells on a short time scale up to 6 hrs (Fig. 4B),
whereas there was an upregulation of pSTAT3 protein after 8 hrs
of palmitate stimulation (Fig. 3B).
The membrane IL-6 receptor protein gp130 showed only
moderate mRNA upregulation (Fig. 3C). Both, STAT3 mRNA
and protein were significantly downregulated after 24 hrs
incubation with 0.25 mM palmitate, which was the most effective
concentration at 48 hrs, too (Fig. 3B, C). Confocal imaging
revealed perinuclear enrichment of pSTAT3 after 48 hrs stimu-
lation with 1 mg/ml LPS (Fig. 5A2) and even more prominent with
0.25 mM palmitate (Fig. 5A3).
SOCS3, SHP2
Since SOCS3 and SHP2 are important regulators of IL-6
signaling pathways, we further examined their regulation by
palmitate and LPS. SOCS3 mRNA and SOCS3 protein
increased after 48 hrs of palmitate treatment (Fig. 6A, B).
SHP2 mRNA and SHP2 protein levels decreased (Fig. 6C, D).
Interestingly, LPS caused upregulation of SOCS3 mRNA in the
first 6 hrs of treatment, but levels returned to baseline level after
48 hrs, while SOCS protein content was highest after 48 hrs
(Fig. 6E, F). SHP2 mRNA and protein levels were unaltered
after LPS treatment (Fig. 6G, H). These findings were
confirmed by confocal immunofluorescence. We found highest
immunoreactivity for pSTAT3, SOCS3, and SHP2 after
palmitate treatment, while the changes were only moderate in
LPS treated cultures (Fig. 5).
NF-kB p65 regulation and activation
NF-kB p65 is the main transcription factor regulating IL-6 gene
expression [20]. We found concentration- and time-dependent
downregulation of the NF-kB p65 mRNA (Fig. S1A, B) and pNF-
kB p65 protein (Fig. 7A, B). This was in striking contrast to the
effect of LPS, which led to concentration-dependent upregulation
of both, NF-kB p65 mRNA (Fig. S1B) and pNF-kB p65 protein
(Fig. 7B).
In double confocal immunofluorecence experiments we found
time-dependent translocation of NF-kB p65 into the nuclei as
evidence of NF-kB activation after 48 hrs of LPS (1 mg/ml) and
palmitate (0.25 mM) stimulation. We found more NF-kB p65 in
nuclei of palmitate stimulated cells than after LPS stimulation. To
quantify this translocation we performed dot blot analysis using a
specific antibody against phosphorylated (Ser536) activated NF-kB
p65. Basic ratio was 2.760.66 (mean6SD) in medium control and
moderate higher in LPS stimulated cells (3.560.92), while the ratio
was significant higher after 48 h of palmitate stimulation
(5.761.1).
Pathway analysis by inhibition of NF-kB (MG132) or MEK1
(PD98059) showed that IL-6 was regulated via NF-kB, but not via
MEK1, whereas MCP-1 was regulated via NF-kB and MEK1
dependent pathways (Fig. 7D, E).
Discussion
Here we studied the effects of palmitate and LPS on human
bladder smooth muscle cells with the aim to elucidate potential
novel mechanisms underlying the observation that urinary tract
infections are more frequent in patients with diabetes mellitus
and take a more severe course [1,2]. Defects in the local urinary
cytokine secretions and an increased adherence of pathogenic
microorganisms to the uroepithelial cells have been discussed as
mechanisms for increased prevalence of UTI in patients with
diabetes [4]. In a proteom study Yohannes et al. [21] found
significant alterations in rat detrusor muscle after streptozoto-
cin-induced diabetes, suggesting that diabetes depending
bladder dysfunction may involve dysregulation of structural
cell integrity, cell adhesion, proliferation and inflammation
[21].
It is well known that during acute infection LPS triggers
intracellular signaling cascades via Toll-like receptor TLR4 that
rapidly induce inflammatory cytokines that initiate a variety of
overlapping immune responses [22].
However, fatty acids and their metabolites act also directly and
indirectly to regulate metabolism and immune function through
their interactions with specific enzymes [23]. Exaggerated and
prolonged postprandial hyperlipidemia is an important character-
istic of diabetic dyslipidemia [7,24].
In the present study we report that palmitate treated human
bladder smooth muscle cells (hBSMC) are a source of MCP-1 and
IL-6. We used specific inhibitors to interfere with the signaling
cascade. We found regulation of IL-6 via NF-kB, which is in line
with the regulation of IL-6 by palmitate stimulation in human
skeletal muscle cells as reported earlier [13].
Unexpectly, pNF-kB p65 protein content was significantly
lower in palmitate stimulated cells as compared to medium control
(Fig. 7A). This finding needs further investigation, since on the
other hand we found short-term upregulation of pNF-kB p65 by
LPS (Fig. 7B). One might suggest that the palmitate stimulus is
much stronger than LPS and might therefore lead to increased
protein turn-over.
MCP-1 also showed NF-kB dependent regulation as recently
reported for IL1b stimulated human aorta smooth muscle cells
Figure 3. Palmitate effects on the expression of IL-6 receptor subunit gp80, gp80soluble, gp130 and pSTAT3. (A) Membrane gp80
receptor mRNA (white bars), soluble gp80 mRNA (black bars). (B) Protein expression of gp80 (white bars) and pSTAT3 (black bars) was measured by
ELISA, and membrane gp130 receptor was analysed by Western blot. (C) Gp130 mRNA (white bars), STAT3 mRNA (black bars). Data are shown as
mean and SEM. mRNA was normalized to natural logarithm LN.
doi:10.1371/journal.pone.0010882.g003
Palmitate Effect on Detrusor
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(PD98059) in hBSMC, indicating regulation via MEK1 pathway
in contrast to IL-6. It is well known that MCP-1 promotes
migration of monocytes [26] and this mechanism has also been
proposed for bladder inflammation [27]. MCP-1 is also related to
insulin resistance and the risk of metabolic syndrome [28].
In hBSMC we found higher secretion of MCP-1 after LPS than
after palmitate stimulation. In contrast IL-6 secretion was much
Figure 4. LPS effects on the expression of IL-6 receptor subunit gp80, gp80soluble, gp130 and pSTAT3. (A) Membrane gp80 receptor
mRNA (white bars), soluble gp80 mRNA (black bars). (B) Protein expression of gp80 (white bars) and pSTAT3 (black bars) was measured by ELISA, and
membrane gp130 receptor was analysed by Western blotting. (C) Gp130 mRNA (white bars), STAT3 mRNA (black bars). Data are shown as mean and
SEM. mRNA was normalized to natural logarithm LN.
doi:10.1371/journal.pone.0010882.g004
Figure 5. Confocal immunofluorescence of cultures treated for 48 hrs with 1 mg/ml LPS or 0.25 mM palmitate. (A1–C1) Medium
control; (A2–C2) LPS treated; (A3–C3) palmitate treated. Cells were double labelled for pSTAT3 (green) and SOCS3 (orange). Monoclonal SHP2 (red)
antibody was used in single labelling experiments. Nuclei were stained with DAPI (blue) recorded with standard fluorescence and merged into the
confocal images. The scale bar in B3 applies to all images except the insets, which have been enlarged two times.
doi:10.1371/journal.pone.0010882.g005
Palmitate Effect on Detrusor
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(Fig. 1, Fig. 2). To the best knowledge of the authors this is the first
study to show that the vast amount of palmitate stimulated IL-6 is
secreted. Only basic cytosolic amounts are detectable (Fig. 1). This
supports the view that the human bladder smooth muscle cells are
involved in immunological processes and may have endocrine
function. To examine possible regulatory function of IL-6 onto
bladder smooth muscle cells we studied the IL-6 receptor pathway
in hBSMC.
The IL-6 signaling cascade depends on the common cytokine
receptor family gp130 subunit and the IL-6 receptor specific gp80
subunit forming a hexameric receptor-IL-6 complex. Gp80 exists
in a membrane-bound and soluble form, produced as alternative
splice variant [29]. For long-term autocrine stimulation by IL-6
the whole receptor complex is needed. We could show, that gp80
mRNA and protein were time-dependent down-regulated by both,
palmitate and LSP (Fig. 3, 4). This implies preferential exocrine
cytokine signaling by BSMC.
We found short term upregulation of pSTAT3 in LPS and
palmitate stimulated cells, but long term downregulation of
pSTAT3 (Fig. 3, 4) in conjunction with upregulation of SOCS3
(Fig. 5), which implies negative feedback to IL-6 signaling as
reported by Croker et al. [30]. Hence it is evident that both,
LSP and palmitate also induced short-term autocrine regulation
of IL-6 receptor pathway. However, conditional knockout
studies have shown that SOCS3 depletion can induce a number
of inflammatory and metabolic disorders [30]. Therefore,
upregulation of SOCS3 could be a protection mechanism
for the hBSMC to cope with chronically elevated IL-6. At
p r e s e n ti ti sn o tk n o w nw h i c hg e nes are regulated by pSTAT3 in
hBSMC.
In conclusion, there is a short-term autocrine IL-6 signaling of
BSMC, but a long-term exocrine IL-6 signaling providing cytokine
stimulation to local or invading cells equipped with the IL-6
receptor complex.
Our study provides evidence for the urinary bladder smooth
muscle cells being an immunologically active tissue, which can be
triggered by inflammatory conditions, but which is especially
sensitive to metabolic alterations as provoked by the saturated FFA
palmitate. In the light of our findings, chronically elevated FFA
could well be a risk factor for urinary infections and idiopathic
bladder inflammation in diabetes.
Materials and Methods
Cell Culture
Human bladder smooth muscle cell (hBSMC) cultures were
established from human detrusor muscle after radical cystectomy
of tumour patients. Written informed consent was obtained from
all patients. The study was approved by the ethics committee of
the University of Leipzig (Reg.No. 773). Cells were grown in SMC
Growth Medium 2 (PromoCell, Heidelberg, Germany) and
subcultured up to the forth passage (P4). At 80% confluence cells
were treated with palmitate or with LPS. Palmitate was used in
combination with 2% bovine serum albumin (BSA) as carrier of
free fatty acids. Medium treated cells were used as control. For
pathway analyses, cells were preincubated for 1 h with 20 mM
PD98059 (Map Kinase Kinase/Erk Kinase 1 inhibitor) or 40 mM
MG123 (proteasome inhibitor; Calbiochem, San Diego, USA). If
not indicated otherwise all chemicals were from Sigma-Aldrich,
Steinheim, Germany.
RNA Extraction and Real Time PCR
Total RNA was isolated with RNeasy Mini kit (Qiagen, Hilden,
Germany). Quantitative PCR was performed with the ABI 7500
Real Time PCR Instrument (Applied Biosystems, Foster, USA)
using the Brilliant SYBR Green QPCR Core Reagent kit
(Stratagene, La Jolla, USA) and custom primers (MWG-Biotech,
Ebersberg, Germany; Table 1). Human 36B4 (acidic ribosomal
phosphoprotein P0) served as internal standard.
Western Blotting
Cells were washed with PBS and scrapped off in 16 lyses
buffer (Cell Signaling, Danvers, USA) supplemented with 1 mM
PMSF and 1/100 volume protease inhibitor cocktail (Sigma-
Aldrich). After sonication, the cell extracts were cleared by
centrifugation. 75 mg of total protein were separated by sodium
dodecyl sulfate polyacrylamide (10%) gel electrophoresis and
transferred to polyvinylidene fluoride (PVDF) membrane by
tank blotting (Mini-PROTEAN II; BioRad, Munich, Germany).
Blots were incubated with primary antibodies for 2 h at
r o o mt e m p e r a t u r eo ro v e rn i g h ta t4 uC. Detection and
visulization was done with horseradish peroxidase-conjugated
anti-rabbit or anti-mouse IgG (1:1000) for 1 h at room
temperature and DAB (FAST 3,39-diaminobenzidine tablets)
as a substrate.
Dot Blot Analysis
Nuclear and cytosolic extracts were prepared according to
Yerneni et al. 1999 [31]. 2 mg total protein of nuclear or cytosolic
extracts were transferred in duplicates on nitrocellulose membrane
by Dot Blotting (Dot Blot 96 System, Biometra, Goettingen,
Germany). After blocking with Odyssee blocking buffer (Licor
Biosciences, Bad Homburg, Germany) for 1 h the membranes
were incubated with anti-Phospho-NF-kB p65 (Ser536) rabbit IgG
(1:1000; Cell Signaling, Danvers, USA) over night at 4uC.
Detection was done with anti-rabbit IRDye 680 (1:5000; Licor
Biosciences) for 2 h. Membranes were scanned with Odyssey
Infrared Imager and evaluated by Odyssey Infrared Imaging
Software 3.0 (Licor Biosciences). Total protein was visualized by
SYPRO Ruby blot stain (BioRad).
Enzyme-linked Immunosorbent Assay (ELISA)
Intracellular and secreted IL-6 was quantified by Quantikine
human IL-6 immunoassay (R&D Systems, Minneapolis, MN). Cell
extracts were diluted 1:10 with calibrator diluent. IL-6 in cell
culture supernatants were measured after being centrifuged in
1:100 diluted samples. IL-6 receptor (gp80) and activated
transcription factors (NF-kB, pSTAT3) were determined in
undiluted cell extracts by Quantikine human IL-6 sR immuno-
assay (R&D Systems) and by PathScan Phospho-NF-kB p65 (pNF-
kB; Ser536) and PathScan Phospho-STAT3 (pSTAT3; Tyr705)
Sandwich ELISA (Cell Signaling). MCP-1 was measured in cell
culture supernatants and cell extracts by Quantikine human
CCL2/MCP-1 immunoassay (R&D Systems). For quantification
Figure 6. Palmitate and LPS effects on SOCS3 and SHP2. Time- and concentration- dependent palmitate effects on SOCS3 mRNA (A), SHP2
mRNA (C), SOCS3 protein expression (B), and SHP2 protein expression (D). LPS effects on SOCS3 mRNA (E), SHP2 mRNA (F), SOCS3 protein expression
(G), and SHP2 protein expression (H). Protein content was analysed in the cytosol using Western blotting analysis. All bars indicate difference to
medium control. For each measurement a medium treated control was used. Data are shown as mean and SEM. Significant differences are indicated
by lines. mRNA was normalized to natural logarithm LN.
doi:10.1371/journal.pone.0010882.g006
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PLoS ONE | www.plosone.org 9 May 2010 | Volume 5 | Issue 5 | e10882Figure 7. Gene regulation and pathway analysis. Time- and concentration-dependent palmitate and LPS effects on pNF-kB protein expression
(A, B). Protein content of pNF-kB was measured in cytosol (A, black bars) and is indicated as difference to medium control (AU in pg/mg) by ELISA. All
bars indicate difference to medium control (A, B). For each measurement a medium treated control was used. Confocal double immunofluorescence
images demonstrate nuclear translocation of NF-kB (green) and IL-6 (red). Nuclei are depicted by DAPI (blue). Dot blot analysis of phosphorylated NF-
kB are shown as ratio of nuclear pNF-kB protein content to cytosolic pNF-kB protein content related to total protein content. Cells were stimulated
for 48 h either with 0.25 mM palmitate or with 1 mg/ml LPS (C). Pathway analysis of palmitate induced IL-6 (D) and MCP-1 (E) regulation. Protein
content was measured by ELISA in supernatants (ng/ml). Cells were stimulated with palmitate (0.5 mM) and inhibitor of proteasomal degradation of
NF-kB (MG132, 40 mM) or MEK1 (PD98059, 20 mM) for 48 hrs. Medium control is indicated as black bar (D, E). Data are shown as mean and SEM.
Significant differences are indicated by lines.
doi:10.1371/journal.pone.0010882.g007
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extracts 5 fold with calibration buffer.
Immunocytochemistry
Cells cultured on cover slips were fixed in 4% buffered
paraformaldehyde and incubated overnight at 4uC with primary
antibodies (Table 2). Indirect immunofluorescence was performed
with secondary antibodies conjugated with Alexa Fluor 488, Alexa
Fluor 555 or Alexa Fluor 633 fluorescent dye (1:500; Invitrogen,
Karlsruhe, Germany). Cell nuclei were stained with 49,6-
diamidino-2-phenylindoldihydro-chloride (DAPI). The cells were
analysed at a confocal laser scanning microscope LSM-5 Pascal
(Carl Zeiss, Jena, Germany).
Statistical Analysis
Complete data analysis was performed using Prism 5.0
(GraphPad Software, La Jolla, USA) statistical software. The data
are presented as the mean +/2 SEM from at least three
independent experiments. Statistical differences were analyzed by
ANOVA. A p-value ,0.05 was considered statistically significant.
Table 1. List of primer pairs used for quantitative PCR.
primer sequence 59R39 product length (bp) binding site
IL-6 forward GGT ACA TCC TCG ACG GCA TCT 81 exon 2
IL-6 reverse GTG CCT CTT TGC TGC TTT CAC exon 3
gp80 forward GGG GGA AGC ACC ATA ACT TT 232 exon 10
gp80 reverse ATC TGG GAC TTC AGG CAC AC exon 10
soluble gp80 forward CTC CCA GGT TCA AGA AGA CG 183 exon 8/10
soluble gp80 reverse TGT GGC TCG AGG TAT TGT CA exon 10
gp130 forward TGT AGA TGG CGG TGA TGG TA 246 exon 17
gp130 reverse CCC TCA GTA CCT GGA CCA AA exon 17
STAT3 forward TGT GCG TAT GGG AAC ACC TA 170 exon 24
STAT3 reverse AGA AGG TCG TCT CCC CCT TA exon 24
SOCS1 forward CTG GGA TGC CGT GTT ATT TT 245 exon 2
SOCS1 reverse TAG GAG GTG CGA GTT CAG GT exon 2
SOCS3 forward TGG TCA GCT GGT CTC CTT TT 231 exon 2
SOCS3 reverse CCC ATC CAG GCT GAG TAT GT exon 2
SH-P2 forward TGG CCA GAC AGA AGC ACA G 165 exon 3
SH-P2 reverse GGC TCT GAT CTC CAC TCG TC exon 3
NF-kB p50 forward ACA AAT GGG CTA CAC CGA AG 238 exon 23
NF-kB p50 reverse ATG GGG CAT TTT GTT GAG AG exon 24
NF-kB p65 forward CCT GGA GCA GGC TAT CAG TC 213 exon 5
NF-kB p65 reverse ATC TTG AGC TCG GCA GTG TT exon 7
MCP1 forward CCC CAG TCA CCT GCT GTT AT 171 exon 2
MCP1 reverse TGG AAT CCT GAA CCC ACT TC exon 3
h36B4 forward AAC ATG CTC AAC ATC TCC CC 397 exon 6
h36B4 reverse CCG ACT CCT CCG ACT CTT C exon 8
doi:10.1371/journal.pone.0010882.t001
Table 2. List of antibodies used for immunocytochemistry.
antigen host type source dilution
human IL-6 mouse monoclonal, IgG2a Acris, Herford, Germany 1:100
human CD126 (IL-6R) mouse monoclonal, IgG1 Acris, Herford, Germany 1:100
human gp130 rabbit polyclonal, IgG Santa Cruz Biotechnology, Heidelberg, Germany 1:100
human pSTAT3 (Tyr705) mouse monoclonal, IgG1 Cell Signaling Technology, Danvers, USA 1:100
human SOCS3 (H-103) rabbit polyclonal, IgG Santa Cruz Biotechnology, Heidelberg, Germany 1:100
human SH-PTP2 (C-18) rabbit polyclonal, IgG Santa Cruz Biotechnology, Heidelberg, Germany 1:100
human NF-kB p65 (F-6) mouse monoclonal, IgG1 Santa Cruz Biotechnology, Heidelberg, Germany 1:100
doi:10.1371/journal.pone.0010882.t002
Palmitate Effect on Detrusor
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Figure S1 Gene regulation of NF-kB p65. Time- and concen-
tration-dependent palmitate and LPS effects on NF-kB p65
mRNA expression (A, B). All bars indicate difference to medium
control. For each measurement a medium treated control was
used. Data are shown as mean and SEM. Significant differences
are indicated by lines. mRNA was normalized to natural logarithm
LN.
Found at: doi:10.1371/journal.pone.0010882.s001 (0.30 MB TIF)
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